SCHAUMBURG, Ill., March 25 /PRNewswire/ -- Sagent Pharmaceuticals, Inc., a privately-held specialty pharmaceutical company, today announced that it has launched Cefepime for injection, USP, a broad ...

More than 2 weeks of treatment with cefepime administered by intravenous (IV) push significantly increases the risk of cefepime-induced neutropenia. A new study has demonstrated that prolonged courses ...

Carbapenem-resistant Enterobacterales and multidrug-resistant Pseudomonas aeruginosa are a global threat to antimicrobial resistance and may be causative pathogens in cUTI. Cefepime-taniborbactam ...

For the above reasons, Medindia cannot be held liable for any action taken based on the information provided by its website. The purpose of this website is to provide initial guidance only and it does ...

June 26, 2012 – The US Food and Drug Administration (FDA) is reminding healthcare professionals about the need to adjust the dosage of the antibacterial drug cefepime in patients with renal impairment ...

Cefepime (Vegapime) is cephalosporin antibiotic, prescribed for certain bacterial infections. It kills sensitive bacteria. The information provided on this page is intended to serve as a comprehensive ...

The FDA has approved the use of B. Braun Medical's Duplex drug delivery system for delivery of FDA-approved 1g and 2g Cefepime for Injection USP and Dextrose Injection USP. Cefepine is used in ...

Cefepime is a β-lactam antibiotic that is cleared through the kidneys. Elimination of cefepime is considerably delayed in patients with impaired renal function, and cefepime has been reported to have ...

MALVERN, Pa. & FLORENCE, Italy--(BUSINESS WIRE)--Venatorx Pharmaceuticals, a private, pre-commercial pharmaceutical company focused on improving health outcomes for patients with multidrug-resistant ...